联系客服

300878 深市 维康药业


首页 公告 维康药业:2020年度财务决算报告

维康药业:2020年度财务决算报告

公告日期:2021-03-31

维康药业:2020年度财务决算报告 PDF查看PDF原文

                        浙江维康药业股份有限公司

                          2020 年度财务决算报告

          一、2020年度财务报表审计情况

          2020年度财务报表经天健会计师事务所(特殊普通合伙)审计,出具了标准

      无保留意见的审计报告(天健审〔2021〕1608号),天健会计师事务所认为公司

      的财务报表已经按照企业会计准则以及有关规定编制,在所有重大方面公允地反

      映了公司2020年12月31日的财务状况以及2020年度经营成果和现金流量。

          二、经营利润情况

                                                                        单位:人民币元

        项 目          2020年度        2019年度      增减幅度    大额变动原因说明

      营业总收入    622,766,990.78  641,800,892.91      -2.97%

      营业成本      171,419,361.62  167,766,169.61        2.18%

      税金及附加      3,473,603.53    5,206,235.19      -33.28%  主要系在建工程增加,相应

                                                                                增值税进项税额增加所致

      销售费用      268,079,813.90  291,797,467.12      -8.13%

      管理费用      28,473,002.63    24,479,431.82      16.31%

      研发费用      20,408,872.40    21,160,217.41      -3.55%

                                                                                主要系募集资金增加,短期

      财务费用      -5,308,241.28      -18,100.36  -29226.72%  贷款减少,增加利息收入降

                                                                                低利息费用所致

      其他收益      30,930,967.14    19,138,913.10      61.61%  主要系本期收到的政府补助

                                                                                增加所致

    信用减值损失    -8,109,410.37    -3,533,150.95    -129.52%  主要系本期应收账款增加所

                                                                                致

    资产处置收益        -3,346.36        88,154.21    -103.80%  主要系上期处置固定资产而

                                                                                产生的利得较多所致

      营业利润      159,038,788.39  147,103,388.48        8.11%

      营业外收入        999,104.92      772,992.29      29.25%  主要系本期税收减免所致


      营业外支出      1,336,018.44      237,040.74      463.62%  主要系本期为新冠肺炎疫情

                                                                                防控工作进行捐款所致

      利润总额      158,701,874.87  147,639,340.03        7.49%

      所得税费用      22,997,391.55    21,626,585.45        6.34%

        净利润      135,704,483.32  126,012,754.58        7.69%

    归属于母公司股  135,815,760.84  126,012,754.58        7.78%

      东的净利润

    少数股东损益      -111,277.52                        100.00%  主要系本期新设非全资子公

                                                                                司所致

      每股收益                2.03            2.09      -2.87%

          三、资产负债情况

                                                                        单位:人民币元

        项 目      2020年12月31日  2019年12月31    增减幅度    大额变动原因说明

                                            日

      货币资金      595,227,638.55  160,885,068.22    269.97%  主要系本期发行股票收到

                                                                        募集资金所致

                                                                        主要系受新冠肺炎疫情爆

      应收账款      285,253,339.93  186,244,780.68      53.16%  发的影响,公司客户销售

                                                                        回款进度有所推迟所致

    应收款项融资      14,422,823.64  23,491,491.48    -38.60%  主要系银行承兑汇票到期

                                                                        兑付所致

      预付款项        16,811,782.92    6,974,949.93    141.03%  主要系预付药品采购款及

                                                                        工程设备款增加所致

      其他应收款        2,847,828.06    2,187,058.46      30.21%  主要系本期零售药店扩

                                                                        张,店铺押金增长所致

        存货          82,305,973.44  60,459,160.20      36.13%  主要系本期客户订单量增

                                                                                加,公司相应备货所致

    其他流动资产      1,746,710.14      699,326.77    149.77%  主要系增值税留抵税额增

                                                                        加所致

    流动资产合计    998,616,096.68  440,941,835.74    126.47%

    其他非流动金融    19,964,000.00                      100.00%  主要系本期对外投资所致

        资产

    投资性房地产      5,850,247.46                      100.00%  主要系本期自有商铺对外

                                                                        出租所致

      固定资产      126,596,577.63  127,557,960.58      -0.75%


      在建工程      422,358,271.68  241,385,367.75      74.97%  主要系大健康产业园项目

                                                                        持续投入所致

      无形资产        30,065,099.99  30,712,706.35      -2.11%

    长期待摊费用      8,726,136.13  11,489,800.48    -24.05%

    递延所得税资产      6,117,202.99    4,932,321.25      24.02%

    其他非流动资产    10,488,758.50  18,848,209.57    -44.35%  主要系本期有商铺办理好权

                                                                                证转到固定资产所致

    非流动资产合计    630,166,294.38  434,926,365.98      44.89%

      资产总计    1,628,782,391.06  875,868,201.72      85.96%

      短期借款        14,713,511.92  28,541,712.92    -48.45%  主要系公司归还上期借款

                                                                        所致

      应付票据        10,223,530.36    5,813,484.28      75.86%  主要系本期增加使用银行

      
[点击查看PDF原文]